PMLT18041 / AGCT1531 / AndolinaResearch Question:
Does monitoring patients with germ cell tumors help prevent tumors from recurring?
Basic Study Information
Purpose:Location: University of Rochester
This phase III trial studies how well active surveillance help doctors to monitor
subjects with low risk germ cell tumors for recurrence after their tumor is removed.
When the germ cell tumors has spread outside of the organ in which it developed, it
is considered metastatic. Drugs used in chemotherapy, such as bleomycin, carboplatin,
etoposide, and cisplatin, work in different ways to stop the growth of tumor cells,
either by killing the cells, by stopping them from dividing, or by stopping them from
spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy
to use in treating metastatic standard risk germ cell tumors.
Lead Researcher (Principal Investigator)
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Thank you for contacting us. People like you are helping URMC make our community and
world a healthier place. We sincerely appreciate your effort. A member of our research
team will be in touch with you.
Trial Not Found
The study you are looking for is not active at this time.
Return to Search